
Allbiosyn is a one-stop raw materials and service platform for nucleic acid therapeutics, catering to the global biomedical industry’s evolving needs. Our primary focus lies in delivering cutting-edge solutions, with a product portfolio spanning from mRNA vaccines,ASO and siRNA drugs to gene sequencing & IVD raw materials. Leveraging our team's pro-found knowledge and skills, we also offer custom synthetic products and services for nucleic acid drug discovery and development to meet customer needs. Allbiosyn brings together top chemical experts from Stanford University, Peking University,…
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.